SG11202105063QA - Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis - Google Patents

Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis

Info

Publication number
SG11202105063QA
SG11202105063QA SG11202105063QA SG11202105063QA SG11202105063QA SG 11202105063Q A SG11202105063Q A SG 11202105063QA SG 11202105063Q A SG11202105063Q A SG 11202105063QA SG 11202105063Q A SG11202105063Q A SG 11202105063QA SG 11202105063Q A SG11202105063Q A SG 11202105063QA
Authority
SG
Singapore
Prior art keywords
imbalanced
class
sets
methods
disease risk
Prior art date
Application number
SG11202105063QA
Inventor
Yolanda Hagar
Gargi Datta
Leigh Alexander
Michael Hinterberg
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of SG11202105063QA publication Critical patent/SG11202105063QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/117—Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4866—Evaluating metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4869—Determining body composition
    • A61B5/4872—Body fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7221—Determining signal validity, reliability or quality
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Artificial Intelligence (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Radiology & Medical Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Fuzzy Systems (AREA)
  • Vascular Medicine (AREA)
  • Optics & Photonics (AREA)
  • Obesity (AREA)
  • Evolutionary Computation (AREA)
  • Mathematical Analysis (AREA)
  • Computational Mathematics (AREA)
  • Algebra (AREA)
  • Mathematical Optimization (AREA)
SG11202105063QA 2018-11-29 2019-11-21 Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis SG11202105063QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862773028P 2018-11-29 2018-11-29
US201862783733P 2018-12-21 2018-12-21
PCT/US2019/062561 WO2020112478A1 (en) 2018-11-29 2019-11-21 Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis

Publications (1)

Publication Number Publication Date
SG11202105063QA true SG11202105063QA (en) 2021-06-29

Family

ID=70852605

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105063QA SG11202105063QA (en) 2018-11-29 2019-11-21 Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis

Country Status (10)

Country Link
US (1) US20220015714A1 (en)
EP (1) EP3886696A4 (en)
JP (1) JP2022509835A (en)
KR (1) KR20210099605A (en)
CN (1) CN113271849B (en)
AU (1) AU2019385818A1 (en)
CA (1) CA3120716A1 (en)
IL (1) IL283467A (en)
SG (1) SG11202105063QA (en)
WO (1) WO2020112478A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11996201B2 (en) * 2021-03-04 2024-05-28 Abbott Laboratories Technology to automatically identify the most relevant health failure risk factors
JP7322918B2 (en) * 2021-03-29 2023-08-08 横河電機株式会社 Program, information processing device, and learning model generation method
KR102393367B1 (en) 2021-11-15 2022-05-03 오브젠 주식회사 Survival analysis system and control method thereof
KR102424884B1 (en) 2021-11-18 2022-07-27 오브젠 주식회사 System comprising survival data refinement server and survival data analysis server, and control method thereof
CN114548327A (en) * 2022-04-27 2022-05-27 湖南工商大学 Software defect prediction method, system, device and medium based on balanced subsets
CN115114270B (en) * 2022-06-14 2024-08-02 马上消费金融股份有限公司 Data downsampling method and device, electronic equipment and computer readable storage medium
KR102688743B1 (en) * 2023-08-16 2024-07-26 렉스이노베이션 주식회사 Method for detecting anomaly based on soh of distributed battery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7982066B2 (en) * 2005-12-09 2011-07-19 Novalife, Inc. High protein supplement
AU2010328019A1 (en) * 2009-12-09 2012-06-28 Aviir, Inc. Biomarker assay for diagnosis and classification of cardiovascular disease
US20120270752A1 (en) * 2011-04-22 2012-10-25 Ge Global Research Analyzing the expression of biomarkers in cells with moments
CN104573708A (en) * 2014-12-19 2015-04-29 天津大学 Ensemble-of-under-sampled extreme learning machine
EP3356560A4 (en) * 2015-09-30 2019-06-12 Inform Genomics, Inc. Systems and methods for predicting treatment-regimen-related outcomes
CN116904572A (en) * 2016-06-08 2023-10-20 爱荷华大学研究基金会 Compositions and methods for detecting susceptibility to cardiovascular disease
GB201614394D0 (en) * 2016-08-23 2016-10-05 Imp Innovations Ltd Method
AU2018100796A4 (en) * 2018-06-14 2018-07-19 Macau University Of Science And Technology A genetic feature identifying system and a search method for identifying features of genetic information

Also Published As

Publication number Publication date
KR20210099605A (en) 2021-08-12
EP3886696A4 (en) 2022-08-24
CN113271849A (en) 2021-08-17
AU2019385818A1 (en) 2021-07-08
US20220015714A1 (en) 2022-01-20
WO2020112478A1 (en) 2020-06-04
EP3886696A1 (en) 2021-10-06
CN113271849B (en) 2024-08-30
IL283467A (en) 2021-07-29
JP2022509835A (en) 2022-01-24
CA3120716A1 (en) 2020-06-04

Similar Documents

Publication Publication Date Title
IL283467A (en) Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis
IL246917B (en) Biomarker and methods for early diagnosis of alzheimer's disease
IL260678B (en) Systems and methods for improving disease diagnosis
SG11201607796TA (en) Nanopore-based analysis of protein characteristics
EP3232198A4 (en) Biomarker for diagnosis of hepatoma and use thereof
GB201504432D0 (en) Materials and methods for diagnosis and treatment of alzheimers disease
EP3376939A4 (en) Automated methods for the objective quantification of retinal characteristics by retinal region and diagnosis of retinal pathology
GB201608781D0 (en) Non-invasive blood analysis
EP3398152A4 (en) Flaw analysis of images
IL240346A0 (en) Means and methods for assessing the quality of a biological sample
HK1247370A1 (en) Tissue sample analysis technique
LT3171174T (en) Lactoferrin for use in the diagnosis or prognosis of alzheimer`s disease
GB201610425D0 (en) Analysis of images of biological material
EP3472611C0 (en) Metagenomic method for in vitro diagnosis of gut dysbiosis
GB201804724D0 (en) Method of diagnosing cceliac disease
PL3580567T3 (en) In vitro method for the diagnosis of lung cancer
GB2570742B (en) Optical-interference analysis
HK1255691A1 (en) Methods for histological diagnosis and treatment of diseases
GB201806002D0 (en) Methods of spectroscopic analysis
GB2579122B (en) Tissue analysis
IL269094A (en) Anti ccl24 (eotaxin2) antibodies for use in the treatment of hepatic diseases
RS62024B1 (en) Igf-1r antibody and its use for the diagnosis of cancer
EP3385698C0 (en) Method for the analysis of surface measurements
EP3446127A4 (en) Biomarkers and methods for assessing response to inflammatory disease therapy
EP3405095C0 (en) Tissue sample analysis